Clin2
NCT06806137Possibly a fitRecruiting

Chickenpox vaccine study for healthy toddlers

Chickenpox

Treatments studied

Part of Infections clinical trials.

This study tests how well a second dose of an investigational chickenpox vaccine works and how safe it is in healthy children. Your child would get the first dose between 12-15 months old, then a booster 3 months later.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
600 people
Ages
1 year to 1.3 years
Study type
Interventional

Who can take part

  • Your child must be 12 to 15 months old when they get the first vaccine dose.
  • Your child must be in good health, with no major medical problems.
  • Your child should not have already had chickenpox or been vaccinated against chickenpox.
  • Your child should not have a weakened immune system or take medicines that affect the immune system.
  • Your child should not have received certain vaccines (MMR, hepatitis A) before the study starts.
  • If you live in a country where a pneumonia booster is given at 12-15 months, your child must have already had the primary pneumonia vaccine series in their first year.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06693895Recruiting· Phase 3
Chickenpox vaccine safety study for healthy toddlers

This study tests a new chickenpox vaccine for healthy children ages 12 to 15 months. It aims to see if the vaccine is safe and helps protect against chickenpox.

Phoenix, Arizona
NCT06740630Recruiting· Phase 3
A chickenpox vaccine study for healthy toddlers 12 to 15 months old

This study tests an experimental chickenpox vaccine to see how well it works and if it's safe. Your child may be able to join if they are healthy and between 12 and 15 months old.

Mobile, Alabama
NCT06855160Recruiting· Phase 3
Chickenpox & MMR Vaccine Study for Healthy Toddlers

This study tests a new chickenpox vaccine combined with a standard MMR vaccine (measles, mumps, rubella) in healthy children aged 12-15 months. The goal is to see how well the vaccines work and how safe they are when given as a shot in the arm.

Tucson, Arizona
NCT06891872Not yet recruiting· Phase 4
Chickenpox vaccine study for toddlers with routine vaccines

This trial tests a live chickenpox vaccine given at the same time as the MMR or DTaP shot for children ages 18 to 24 months. It may help protect your child from chickenpox while keeping their regular vaccine schedule on track.

Chongqing
NCT07473427Not yet recruiting· Phase 3
Chickenpox vaccine study for healthy children in Vietnam

This trial tests a chickenpox vaccine in healthy children ages 1 to 12 to see how well it works and if it's safe. If your child has never had chickenpox or the vaccine, or had one dose at least 3 months ago, they may be able to join.

Hanoi
NCT07415252Not yet recruiting· Phase 3
Varicella vaccine trial for healthy children ages 1 to 12

This study tests a lower-dose varicella (chickenpox) vaccine in healthy children. It aims to see if the vaccine works and is safe. Your child may be able to join if they haven't had chickenpox or the vaccine before.

San Pedro Sula, Cortés Department

Hear when a new Chickenpox trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.